AstraZeneca PLC (LON:0A4J)
London · Delayed Price · Currency is GBP · Price in USD 83.96
0.00 (0.00%)
At close: Oct 2, 2025
AstraZeneca Market Cap
AstraZeneca has a market cap or net worth of 196.16 billion as of October 3, 2025. Its market cap has increased by 9.82% in one year.
Market Cap
196.16B
Enterprise Value
215.08B
Revenue
41.24B
Ranking
n/a
PE Ratio
32.40
Stock Price
83.96
Market Cap Chart
Since May 28, 1993, AstraZeneca's market cap has increased from 4.55B to 196.16B, an increase of 4,210.91%. That is a compound annual growth rate of 12.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 3, 2025 | 196.16B | 20.87% |
| Dec 31, 2024 | 162.29B | -1.22% |
| Dec 29, 2023 | 164.29B | -5.48% |
| Dec 30, 2022 | 173.83B | 29.30% |
| Dec 31, 2021 | 134.44B | 39.83% |
| Dec 31, 2020 | 96.14B | -3.67% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 196.16B |
| HSBC Holdings | 182.89B |
| Shell | 156.99B |
| Unilever | 109.34B |
| Rolls-Royce Holdings | 98.05B |
| Rio Tinto Group | 84.56B |
| British American Tobacco p.l.c. | 83.19B |
| GSK plc | 65.55B |